KIR3DL1 and myeloid sarcoma: Hollenbach et al. conducted a study in an African American cohort that reinforced the protective role of the KIR3DL1 ligand HLA-Bw4 against MS, highlighting its functional significance across diverse ancestral backgrounds [85].